Page last updated: 2024-09-04

cyclohexadienone and ER-Negative PR-Negative HER2-Negative Breast Cancer

cyclohexadienone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Altei, WF; Andricopulo, AD; Coelho, F; Fernandes, DC; Gomes, RC; Martins, LJ; Pachane, BC; Santos, RN; Selistre-de-Araújo, HS	1

Other Studies

1 other study(ies) available for cyclohexadienone and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration. Anti-cancer agents in medicinal chemistry, 2021, Volume: 21, Issue:14 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclohexenes; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Polymerization; Spiro Compounds; Triple Negative Breast Neoplasms; Tubulin; Tubulin Modulators	2021

Article

Year

Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration.

Anti-cancer agents in medicinal chemistry, 2021, Volume: 21, Issue:14

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclohexenes; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Polymerization; Spiro Compounds; Triple Negative Breast Neoplasms; Tubulin; Tubulin Modulators

2021